UNSPSC 51282609: Cefepime dihydrochloride monohydrate

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I8X1O0607P. European Medicines Agency schedules Cefepime dihydrochloride monohydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26333. Cefepime dihydrochloride monohydrate generally arises in the molecular formula C19H24N6O5S2.2CLH.H2O. The term 'cefepime dihydrochloride monohydrate' is a European Pharmacopoeia designation.

Most nations, for tariff and trade purposes, schedule cefepime dihydrochloride monohydrate under HS 29419000. SMILES: C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)[O-].O.CL.CL.

UNSPSC 51282609 Cefepime dihydrochloride monohydrate is a Commodity code covering a specific pharmaceutical active ingredient; however, the recent state and local opportunities tagged under this code do not reflect procurement of cefepime itself, but rather of broader medical supplies, naloxone, pharmacy benefit programs, and multi-source generic pharmaceuticals. The code shows limited relevance to actual recent state and local solicitations, suggesting either a tagging mismatch or that cefepime procurement does not currently appear in state and local public notices at scale. When state and local governments do procure pharmaceuticals—as shown in the Seminole County, Texas HHS, City of Tampa, and Minnesota cooperative purchasing opportunities—they typically source through wholesaler networks, group purchasing organizations, or direct-to-manufacturer agreements rather than by individual active ingredient.

Recent activity spans county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing alliances. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems; the Texas Health and Human Services Commission released an RFI (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription programs; the City of Tampa issued an IFB (26P00145, due March 13, 2026) for medical and first aid supplies to the Fire Department, estimated at $700,000, with a Small Local Business Enterprise set-aside and 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across participating state and local facilities including Oregon, requiring distribution through three authorized wholesalers. Geographic activity includes Florida, Texas, Minnesota, and Oregon, though the cefepime code itself shows no decision-relevant recent opportunity volume.